In COPD patients, the incidence of increased HCT and Hb levels (polycythemia) is immensely reduced due to the implementation of close follow-up and LTOT, whereas low Hb (anemia) has become a concern nowadays [65]. The gene discussed is GSTM1; the disease is anemia (phenotype).